Results 201 to 210 of about 376,311 (300)

Cytokine release syndrome in solid tumors

Cancer, Volume 131, Issue 17, 1 September 2025.
Abstract Cytokine release syndrome (CRS) is a common and potentially severe complication of cancer immunotherapy, including CAR T‐cell therapies, bispecific T‐cell engagers, and less commonly immune checkpoint inhibitors. Although extensive research has established guidelines for managing CRS in hematological malignancies, there is a growing need to ...
David Synnott, David O’Reilly, Declan De Freitas, Jarushka Naidoo   +3 more
wiley   +1 more source

Intralesional acyclovir versus intralesional Hepatitis-B vaccine in treatment of resistant plantar warts: a randomized controlled trial. [PDF]

Arch Dermatol Res
Gharib K, Taha A, Elradi M.
europepmc   +1 more source

Hepatitis B Vaccine in national immunization schedule: A preventive step in India

Human Vaccines, 2011
R. Verma, Pardeep Khanna, S. Prinja, M. Rajput, S. Chawla, Mohan Bairwa   +5 more
semanticscholar   +1 more source

Influence of Pre‐Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross‐Sectional Study

Cancer Reports, Volume 8, Issue 9, September 2025.
ABSTRACT Background and Aims Human papillomavirus (HPV) vaccines have been available in China for only 8 years, and routine HPV testing is not recommended prior to vaccination. Therefore, evaluation of HPV vaccine effectiveness and the impact of pre‐vaccination HPV infection status on vaccine protective effect in Chinese women is warranted.
Lucia Li, Haiyue Wu, Yibo Chen, Zhanjun Shen, Kun Fu, Minghui Qiu, Yingzhen Liu, Yufei Shen, Yingnan Lu, Xinxin Wen, Siyu Yang, Kehan Zou, Hui Zhang, Yangzong Gesang, Haojie Huang, Chao Zhao, Pengming Sun, Lisha Wu, Yu Zhang   +18 more
wiley   +1 more source

Comedications Associated with Immune‐Related Adverse Events from Immune‐Checkpoint Inhibitors

Clinical Pharmacology &Therapeutics, Volume 118, Issue 3, Page 593-599, September 2025.
Immune‐checkpoint inhibitors (ICI) have revolutionized cancer treatment but are responsible for various immune‐related adverse events (irAE). The impact of non‐anticancer medications (comedications) on irAE occurrence remains largely unexplored. The objective of this study was to assess comedications associated with an increased reporting of irAE with ...
Léonard Laurent, Baptiste Abbar, Kevin Bihan, Elise Dumas, Floriane Jochum, Bénédicte Lebrun‐Vignes, Jean‐Philippe Spano, Joe‐Elie Salem, Anne‐Sophie Hamy, Fabien Reyal, Paul Gougis   +10 more
wiley   +1 more source

Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis. [PDF]

BMC Pediatr
Geta M, Yizengaw E, Manyazewal T.
europepmc   +1 more source

State‐of‐the‐Art Fabrication of Microneedle Patches: A Mini‐Review on Emerging Techniques

MedComm – Biomaterials and Applications, Volume 4, Issue 3, September 2025.
This mini‐review explores state‐of‐the‐art microneedle (MN) fabrication techniques, comparing conventional and emerging methods such as electrospinning and bioprinting. The analysis highlights advancements in precision, scalability, and material compatibility, offering insights into optimizing MN design for transdermal drug delivery, diagnostics, and ...
Syed Waqas Ali Shah, Xingxing Li, Hao Yuan, Huiling Shen, Guifang Pan, Hanhan Xie, Jundong Shao   +6 more
wiley   +1 more source

Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis. [PDF]

Trop Med Health
Olakunde BO, Ifeorah IM, Adeyinka DA, Olakunde OA, Ogundipe T, Olawepo JO, Ezeanolue EE.   +6 more
europepmc   +1 more source

Considerations for hepatitis B as part of a combination vaccine

, 2001
David P. Greenberg
openalex   +1 more source

Recent Progress in Gene Delivery Systems Based on Gemini‐Surfactant

MedComm – Future Medicine, Volume 4, Issue 3, September 2025.
Gene delivery is a key area in biomedicine, where nucleic acids are delivered into cells to treat diseases by modulating genes. The low micelle concentration, effective nucleic acid complexation, and low immunogenicity make Gemini surfactants promising gene delivery vectors.
Peng Qian, Yuxin Chen, Yangchen Xing, Kexin Wu, Qianyu Zhang, Huali Chen   +5 more
wiley   +1 more source